Target intelligence / Profile preview

SEC14-like lipid-binding protein (SEC14L)

Target
SEC14L
Molecular classification
Transporter, Lipid-binding protein, Enzyme, GTPase
01

Overview

SEC14-like vitamin E transport proteins, primarily represented by the SEC14L family and alpha-tocopherol transfer protein (TTPA), are essential intracellular transporters that manage the distribution of lipophilic antioxidants and lipids. These proteins are defined by the presence of a SEC14 (or CRAL-TRIO) domain, which forms a specialized hydrophobic pocket capable of sequestering and transferring molecules like alpha-tocopherol and squalene between cellular membranes. TTPA is the most critical member for systemic vitamin E homeostasis, as it facilitates the secretion of alpha-tocopherol from the liver into the bloodstream. Other members, such as SEC14L2 (also known as tocopherol-associated protein 1 or supernatant protein factor), play diverse roles including the stimulation of cholesterol biosynthesis and acting as tumor suppressors in various cancers. Mutations in these proteins, particularly TTPA, are linked to severe neurodegenerative disorders such as ataxia with vitamin E deficiency (AVED). Due to their central role in lipid signaling and antioxidant protection, they are subjects of research in oncology, infectious diseases like Hepatitis C, and metabolic disorders.

Other names
SEC14-like vitamin E transport proteinTocopherol-associated proteinTAPSupernatant protein factorSPFCRAL-TRIO domain-containing proteinAlpha-tocopherol transfer protein
02

Mechanism of action

Facilitates the intracellular transport and exchange of lipophilic ligands, such as alpha-tocopherol and squalene, between membranes; also acts as a co-factor or stimulator for enzymes like squalene monooxygenase and can modulate gene expression upon ligand binding.

03

Biological functions

Vitamin E transportLipid homeostasisCholesterol biosynthesisSignal transductionTumor suppressionAntioxidant defense
04

Disease associations

Ataxia with vitamin E deficiencyProstate cancerHepatocellular carcinomaHepatitis CNeurodegenerative disease
05

Safety considerations

Vitamin E deficiencyDisruption of lipid metabolismPotential off-target effects on cholesterol biosynthesis
06

Interacting drugs

Alpha-tocopherol

1 more in the full profile.

07

Biomarkers

Serum alpha-tocopherol levels

Beyond the preview

Go deeper on SEC14-like lipid-binding protein (SEC14L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEC14-like lipid-binding protein (SEC14L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call